The well documented over-expression of LAT1 in cancer is also explained by the presence, in the promoter region, of a canonical binding site for the proto-oncogene c-Myc (Hayashi et al., 2012) that, interestingly, regulates glucose metabolism (Kim et al., 2004). This evidence concerns the gene SLC7A5 and cancer.